Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000548172 | SCV000644429 | benign | Tuberous sclerosis 2 | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001020102 | SCV001181535 | likely benign | Hereditary cancer-predisposing syndrome | 2021-05-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001551674 | SCV001772233 | likely benign | not provided | 2019-07-29 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV001551674 | SCV002011332 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000548172 | SCV002039738 | likely benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001020102 | SCV002533391 | likely benign | Hereditary cancer-predisposing syndrome | 2021-12-29 | criteria provided, single submitter | curation |